Pharmaceutical Investors Favor Obesity Treatments Over Cancer Drugs
Pharmaceutical giants Eli Lilly and Novo Nordisk have seen their value more than triple in less than three years. Their combined corporate value, which consists of market capitalization plus net debt, was around $360 billion at the height of the COVID-19 pandemic in February 2021. It has since grown to a trillion dollars.The rapid rise […]